Module code: BMD375
Credits: 15.0
Semester: SEM1
Timetable:
Seminar- Semester 1: Weeks 3, 5, 8, 10: Monday 11 am - 1 pm
Tutorial- Semester 1: Weeks 4, 6, 9, 11: Monday 11 am - 12 pm
Lecture- Semester 1: Weeks 1, 2, 4, 5, 6, 8, 9, 10, 11: Monday 9 am - 11 am
- Semester 1: Weeks 2: Friday 4 pm - 5 pm
- Semester 1: Weeks 3: Monday 10 am - 11 am
- Semester 2: Weeks 6: Thursday 1 pm - 2 pm
Contact: Prof Michele Bombardieri
Overlap: None
Prerequisite: None
Students will be exposed to innovative therapeutics in areas including vaccines, oncology, cardiovascular, metabolic diseases, pain and neuroscience, inflammation and immunology as well as rare disorders. Students will also gain awareness into challenges that the pharmaceutical industries face. Lectures will cover topics such as drug shortages, targeted/personalised drugs, use of biomarkers, clinical trial design, drug safety, risk/benefit assessments, collaboration between patient, academia, industry and the regulatory community, international collaborations, policy and bioethics, novel tools for scientific/clinical communication, sustainability of innovation/financial models of product development/pricing, marketing and licencing. Introductory lectures will be followed by lectures in specialized areas of the subject given by experts in both academia and industry. In addition to formal lectures and interactive seminars, the course will provide tutorials with opportunities to critically-evaluate research papers. We will offer practical workshop sessions to reinforce the lectures.
Connected course(s): UDF DATA
Assessment: 80.0% Examination, 20.0% Coursework
Level: 6
